2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol

C62H76FN21O5 — CID 165011903

IUPAC2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol
SMILESCC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC2(CC2)N1.[2H]C([2H])([2H])n1cc(-c2cnc(-c3ccc(N[C@@H]4CC(C)(C)NC(C)(C)[C@@H]4F)nn3)c(O)c2)cn1
InChIInChI=1S/C22H28FN7O.C20H23N7O2.C20H25N7O2/c1-21(2)9-16(20(23)22(3,4)29-21)26-18-7-6-15(27-28-18)19-17(31)8-13(10-24-19)14-11-25-30(5)12-14;1-19(2)10-14(11-20(26-19)5-6-20)29-17-4-3-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27;1-19(2)10-14(11-20(3,4)26-19)29-17-6-5-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27/h6-8,10-12,16,20,29,31H,9H2,1-5H3,(H,26,28);3-4,7-9,12,14,26,28H,5-6,10-11H2,1-2H3;5-9,12,14,26,28H,10-11H2,1-4H3/t16-,20-;;/m1../s1/i5D3;;
InChIKeyJVHBUSHPBDZVAE-YNBGATGRSA-N
MW1217.45 g/mol
LogP8.09
Rot. Bonds13

About 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol

2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol (PubChem CID 165011903) has the molecular formula C62H76FN21O5 and a molecular weight of 1217.45 g/mol. Its IUPAC name is 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol.

Molecular Properties

Compound Name2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol
PubChem CID165011903
Molecular FormulaC62H76FN21O5
Molecular Weight1217.45 g/mol
Exact Mass1216.65
IUPAC Name2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol
SMILESCC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC2(CC2)N1.[2H]C([2H])([2H])n1cc(-c2cnc(-c3ccc(N[C@@H]4CC(C)(C)NC(C)(C)[C@@H]4F)nn3)c(O)c2)cn1
InChIInChI=1S/C22H28FN7O.C20H23N7O2.C20H25N7O2/c1-21(2)9-16(20(23)22(3,4)29-21)26-18-7-6-15(27-28-18)19-17(31)8-13(10-24-19)14-11-25-30(5)12-14;1-19(2)10-14(11-20(26-19)5-6-20)29-17-4-3-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27;1-19(2)10-14(11-20(3,4)26-19)29-17-6-5-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27/h6-8,10-12,16,20,29,31H,9H2,1-5H3,(H,26,28);3-4,7-9,12,14,26,28H,5-6,10-11H2,1-2H3;5-9,12,14,26,28H,10-11H2,1-4H3/t16-,20-;;/m1../s1/i5D3;;
InChIKeyJVHBUSHPBDZVAE-YNBGATGRSA-N
XLogP8.09
TPSA322.52 Ų
H-Bond Donors7
H-Bond Acceptors26
Rotatable Bonds13
Heavy Atoms89
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001217.45
LogP ≤ 58.09
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1026

Analyze 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol?
The IUPAC name of 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol (CID 165011903) is 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol.
What is the SMILES notation for 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol?
The canonical SMILES for 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol is CC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC(C)(C)N1.CC1(C)CC(Oc2ccc(-c3ncc(-n4nccn4)cc3O)nn2)CC2(CC2)N1.[2H]C([2H])([2H])n1cc(-c2cnc(-c3ccc(N[C@@H]4CC(C)(C)NC(C)(C)[C@@H]4F)nn3)c(O)c2)cn1.
What is the InChIKey of 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol?
The InChIKey is JVHBUSHPBDZVAE-YNBGATGRSA-N. The full InChI is InChI=1S/C22H28FN7O.C20H23N7O2.C20H25N7O2/c1-21(2)9-16(20(23)22(3,4)29-21)26-18-7-6-15(27-28-18)19-17(31)8-13(10-24-19)14-11-25-30(5)12-14;1-19(2)10-14(11-20(26-19)5-6-20)29-17-4-3-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27;1-19(2)10-14(11-20(3,4)26-19)29-17-6-5-15(24-25-17)18-16(28)9-13(12-21-18)27-22-7-8-23-27/h6-8,10-12,16,20,29,31H,9H2,1-5H3,(H,26,28);3-4,7-9,12,14,26,28H,5-6,10-11H2,1-2H3;5-9,12,14,26,28H,10-11H2,1-4H3/t16-,20-;;/m1../s1/i5D3;;.
What are the key properties of 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol?
2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol has a molecular weight of 1217.45 g/mol, XLogP of 8.09, 13 rotatable bonds, 7 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-[(5,5-dimethyl-4-azaspiro[2.5]octan-7-yl)oxy]pyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol;2-[6-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]pyridazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]pyridin-3-ol;2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(triazol-2-yl)pyridin-3-ol is sourced from PubChem (CID 165011903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).